de Roest, R H, van der Heijden, M, Wesseling, F W R, de Ruiter, E J, Heymans, M W, Terhaard, C, Vergeer, M R, Buter, J, Devriese, L A, de Boer, J P, Navran, A, Hoeben, A, Vens, C, van den Brekel, M, Brakenhoff, R H, Leemans, C R & Hoebers, F 2022, ' Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer ', Radiotherapy and Oncology, vol. 175, pp. 112-121 . https://doi.org/10.1016/j.radonc.2022.08.013 Radiotherapy and Oncology, 175, 112-121. Elsevier Ireland Ltd Radiotherapy and oncology, 175, 112-121. Elsevier Ireland Ltd
Gahrmann, R, Smits, M, Vernhout, R M, Taal, W, Kapsas, G, de Groot, J C, Hanse, M, Vos, M, Beerepoot, L V, Buter, J, Flach, Z H, van der Holt, B & van den Bent, M 2022, ' The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab ', Neuro-oncology advances, vol. 4, no. 1, vdac032 . https://doi.org/10.1093/noajnl/vdac032 Neuro-Oncology Advances, 4(1):vdac032. Oxford University Press Neuro-oncology advances, 4(1):vdac032. Oxford University Press Neuro-oncology advances, 4(1):vdac032